Augnito Voice Services™ will integrate with Intelerad’s InSight PACS reporting, equipping clients with accessible, advanced speech recognition technology that simplifies patient care.

This new integration partnership will provide Intelerad clients with increased voice recognition options, giving them access to a pioneering, cloud-based product that helps ensure clients are not limited to one voice recognition platform and the risks associated with that dependence.
Intelerad Cloud is a menu of expertly cloud-engineered solutions designed to optimise the benefits of Cloud technology and scalability potential without sacrificing the performance of onsite architecture. Proudly vendor-neutral, Intelerad, is integrating its products with multiple technologies which fit with its cloud-based strategy, Augnito being the most recent. These can assist with the Cloud First strategy by utilising the Cloud for disaster recovery, image exchange and long-term archiving, and this latest addition is another way Intelerad is providing the latest cloud innovations and future resilience required by its clients.

Augnito can be used with a speech microphone or even through an app on a smartphone, making it faster and easier for radiologists and clinicians to diagnose critical conditions where every second counts, leading to better outcomes for patients.

Shiraz Austin, Managing Director at Scribetech (UK) Ltd and Co-Founder of Augnito stated, “Intelerad is a best-in-class provider of medical imaging software with a mission statement that dovetails very well into our own – where technology is developed to impact healthcare in a positive way and where making more time for patient care is paramount. Our partnership agreement solidifies the solution strategies of both organisations, and we’re excited that our secure, cloud-based, voice-powered AI speech recognition technology, Augnito, will play an important role in achieving this. Through the use of Augnito technology, Intelerad can empower radiologists to deliver reporting when and where it’s needed to keep the patient journey and clinical workflows moving.”

Intelerad is exploring integrating Augnito into other products in its portfolio, Arron Edwards, Managing Director of Intelerad, commented, “Intelerad is excited to be able to add the class-leading, cloud-based speech engine from Augnito into our fully featured rich reporting solution, which is built into InSight PACS. Our UK engineering team have worked hand-in-hand with the Augnito engineering team at Scribetech, leading to an incredibly successful integration which will ensure that we can continue to offer a best-in-class solution for our clients.”

ENDS
For further information, please contact:
Clare Dawe, Marketing Manager, Insignia Medical Systems powered by Intelerad
01256 247 010
[email protected]

ABOUT INTELERAD
Intelerad is one of the leading providers of medical imaging software and services for the healthcare industry. Headquartered in Raleigh, NC and Montreal, Quebec, Intelerad has over 900 employees located in offices across six countries. Nearly 2,500 healthcare organizations around the world rely on Intelerad products to manage patient data, helping them reduce time and workload while improving patient outcomes. Intelerad’s award-winning enterprise imaging solutions have been recognized globally by KLAS, with Intelerad’s Ambra Health ranked #1 in Image Exchange for eight consecutive years. To learn more, visit intelerad.com.

Intelerad welcomes contact from PRs and journalists for quotes, expert opinions or bespoke content for particular press articles. Please contact Clare Dawe in the first instance at [email protected]

ABOUT SCRIBETECH AND THE AUGNITO SOLUTION
Augnito is a secure, cloud-based, AI-driven clinical speech recognition product suite. It offers fast, easy ways to capture live clinical data on any device with 99.3% accuracy, support for multiple medical specialties, and no need for voice profile training. Augnito brings seamless speech recognition to daily workflows and third-party clinical systems, turning medical information into clinical documentation and making healthcare intelligence securely accessible wherever it’s needed. Augnito was co-developed by Scribetech, a clinical voice solutions innovator, fusing 20 years of transcription and digital dictation services to the NHS, speech-to-text, and clinical coding solutions for the healthcare sector, and its own speech recognition engine with advanced voice AI technology. Follow us on Linked-In.

 

[London, 29 March 2023] – With the NHS struggling to meet the demands of an ageing population, complex discharge processes, and widespread bed shortages, new technology has an important role to play in safeguarding patient outcomes.

The past few years have been incredibly challenging for the NHS, with the pandemic and heightened demand bringing longstanding problems into sharp, urgent focus. Bed shortages continue to be a major issue, with British Medical Association data from December 2022 reporting that occupancy rates consistently exceed safe levels. Meanwhile, Delayed Transfers of Care (DTOCs) create unnecessary bottlenecks, with patients occupying beds when they are clinically ready to be discharged or transferred.

For NHS Trusts, this creates a significant, largely unnecessary cost – one that’s hard to immediately address by adding new bed stocks. That’s why Scribetech, the co-creators of AI speech recognition solution Augnito, are working to help Trusts understand the potential of innovative new technology.

“For decades, the NHS has tried to address bed stock and occupancy issues by adding more beds, but we have consistently seen that it’s almost impossible to keep up with demand” stated Shiraz Austin, Managing Director at Scribetech and Co-Founder of Augnito. “Technology and changes in ways of working have the potential to reduce occupancy rates and improve care in a way that’s more sustainable. But this transformation is only possible if it makes financial sense.”

Estimating the financial cost of DTOCs and the bed shortage is difficult. Department of Health figures put the cost of a DTOC bed at £400/day, while Age UK report 2019 costs of £346/day. Using a forgiving cost of £350/day, this implies a bill in excess of £54 million just for the delayed days in February 2020, when DTOC metrics were last reported.

Speech recognition technology like Augnito can’t immediately eliminate all DTOCs, but it can deliver consistent, incremental improvements to the workflows of multidisciplinary teams (MDTs). With real time dictation and transcription in any platform or dedicated desktop and smartphone applications, healthcare professionals can reduce the risk of delays arising from inaccurate records, lost records, and breakdowns in communication.

Austin continued: “The financial outlook is clear: the cost of new technology is significantly less than the cost of delays and low bed stocks. The cost of a single extra bed per day is 10 times the cost of an Augnito licence for a month. But that commercial reality is just one part of the picture. There’s a human cost that must also be considered.”

While delays and occupied beds affect every patient – and, indeed, the entire healthcare system including social care – some particularly vulnerable groups are disproportionately affected. December 2021 saw intensive care beds for children reach record occupancy of 89% across the country. Meanwhile, older patients are particularly at risk given the typical complexity of their discharge or transfer to other providers.

When paediatric beds simply aren’t available or elderly patients are kept on wards for weeks, even months after they’re ready to be transferred, their experience is resoundingly negative. They’re unable to receive the care that is appropriate, when it is required, in the right setting. In some cases, this comes with a very real and measurable impact on outcomes.

Austin concluded: “Augnito is designed to work for NHS Trusts – a cloud-hosted technology that’s significantly lower in cost than unnecessary delays and can be implemented quickly and easily. But it’s also designed to empower healthcare professionals and multidisciplinary teams to work efficiently, so they can act based on what patients need, without being limited by processes and old, outdated workflows.”

END

Notes to editors
Full blog posts referenced in this media alert:
https://www.scribetech.co.uk/2023/02/28/how-speech-recognition-technology-can-support-a-national-bed-shortage/
https://www.scribetech.co.uk/2023/03/15/reducing-dtoc-on-vulnerable-patients/

For further information, interview opportunities or accompanying graphics please contact: [email protected]

About Scribetech and the Augnito solution – visit https://www.scribetech.co.uk/ for details and follow us on Linked-In.
Augnito is a secure, cloud-based, AI-driven clinical speech recognition product suite. It offers fast, easy ways to capture live clinical data on any device with 99.3% accuracy, support for multiple medical specialities, and no need for voice profile training. Augnito brings seamless speech recognition to daily workflows and third-party clinical systems, turning medical information into clinical documentation and making healthcare intelligence securely accessible wherever it’s needed. Augnito was co-developed by Scribetech, a clinical voice solutions innovator, fusing 20 years of transcription and digital dictation services to the NHS, speech-to-text, and clinical coding solutions for the healthcare sector, and its own speech recognition engine with advanced voice AI technology.

[London, 10 February 2023] – As the NHS continues to address and reduce Delayed Transfer of Care (DTOC) incidents – and their associated costs – speech recognition has the potential to deliver transformative efficiency gains.

With the healthcare system under unprecedented pressure, NHS Trusts are reflecting on key metrics associated with performance, cost, and quality of patient care. Delayed Transfers of Care (DTOCs) see patients continue to occupy beds when they are clinically ready to be transferred or discharged. This results in significant expense to the NHS, a lack of available bed stocks, and disrupted journeys for both the patients waiting for transfer and those waiting for beds.

According to Scribetech, UK distributors of Augnito, a cloud-based, AI-powered speech recognition solution, new technology and workflow transformation have the potential to significantly improve how DTOC is managed.

“DTOCs are an indicator of how healthy the health and social care systems are,” stated Shiraz Austin, Managing Director at Scribetech (UK) Ltd and Co-Founder of Augnito.ai. “When patients continue to occupy beds they don’t clinically need, there’s a ripple effect that stretches across the patient journey. This includes delays to treatment for new patients, as well as a considerable amount of distress for those needlessly held in hospital.”

The scale of the DTOC problem is significant. In February 2020, reports show, there were an average of 5370 people delayed per day across the NHS in England – some attributable to the NHS, some attributable to social care, and some with joint responsibility. Based on the Department of Health’s reported costs of an excess bed per day (£350 – £400), the estimated cost of DTOC was as high as £2,148,000 per day for that month alone.

However, this immediate financial impact is just one consequence of DTOCs. With bed stocks at an all-time low and occupancy at an all-time high, DTOCs directly affect the availability of treatment, making acute care when a bed is finally available even more costly and negatively affecting patient outcomes.

Innovative new technology has the potential to positively influence these outcomes – but Austin remains realistic about the results.

Austin continued: “It’s not that technology like Augnito can solve the DTOC challenge overnight. It’s that incremental improvements to the way healthcare professionals work, collaborate, and share information eliminate the low-hanging fruit of slow reporting and typing into cumbersome, often outdated, systems. And time saved leads to reduced cost, where budgets can be repurposed into wider, systemic changes.”

Augnito was designed in partnership with healthcare professionals to address their biggest challenges. This includes bringing real-time SR to the clinical systems used as part of the discharge and transfer process, allowing people to work faster and more flexibly.

Adopted widely, Augnito can deliver:

– Faster reporting time and fewer internal delays to patient discharge or transfer
– Reduced costs, which can be repurposed into growing bed stocks and community nursing
– Increased bed availability with less waste and lower occupancy
– A way to offset the removal of the Government’s Covid-19 DTOC funding

As standard, Augnito empowers healthcare professionals with advanced SR on any device – desktops, web browsers, and mobiles. With a flexible SDK and API, Augnito can also be integrated into existing systems for accurate, immediate capture into an Electronic Patient Record.

Based on February 2020 DTOC data, just a small reduction in turnaround time, inaccuracies and errors could save the NHS hundreds of thousands  per month. Austin concluded: “Augnito creates a more seamless way of working for healthcare professionals, helping with considerable workloads and backlogs. But its real impact is on the NHS as a whole, improving financial drainage and removing the bottlenecks that become obstacles to outstanding patient care and the best possible outcomes.”

END

Notes to editors
Read the full blog post here www.scribetech.co.uk/2023/01/31/can-the-advantages-of-clinical-voice-ai-sr-technology-help-reduce-dtoc

For further information, interview opportunities or accompanying graphics please contact: [email protected]

About Scribetech and the Augnito solution – visit https://www.scribetech.co.uk/ for details and follow us on Linked-In.

About Augnito India Private Limited – visit Augnito.ai.

[London, 31 January 2023] – Scribetech has been re-appointed to the NHS Commercial Solutions Framework Agreement for the provision of digital dictation, speech/voice recognition, outsourced transcription and associated services in all four of the authority’s lots.

Scribetech (UK) Ltd has been re-awarded its third consecutive listing, since 2010, on the NHS Commercial Solutions Framework following the contracting authority’s comprehensive information gathering and tender evaluation process.

Scribetech will see its Textflow digital dictation solution and Augnito voice-AI speech recognition products offered to all NHS organisations.

The four lots under the NHS Commercial Solution framework agreement for which a product or services provider is invited to tender include: Products and/or Services Catalogue; In-house and Outsourced Digital Dictation Service Solution, Outsourced Transcription Service Solution, and Managed Service Solution.

Formed in 2007, and based in the South East of England, the NHS Commercial Solution Framework is a non-profit procurement shared services hub providing collaborative solutions and end-to-end services that combine data analytics and its dedicated category specialists’ in-depth knowledge of supply markets to address stakeholder needs. Categories include: corporate services, digital, estate and facilities, pharmacy, workforce and staffing, and clinical. These services are offered and provided across the NHS and the wider public sector, supporting acute, mental health, community, ambulance trusts, and commissioning organisations.

To date, NHS Commercial Solutions has saved in excess of £230 million for its customers, based on year one project savings alone.

Scribetech has long been recognised as a pioneering clinical transcription services and medical documentation company that has consistently ranked top on multiple NHS Framework contracts since 2005. “We are extremely pleased with the NHS Commercial Solutions award. It validates not only Scribetech’s vision and our digital dictation technology and voice-AI capabilities, but the ability to provide NHS organisations with cost-effective solutions that really do address many of the core issues that confront medical professionals on the healthcare frontline, such as improving efficiency and accuracy, as well as optimising clinical workflows, resources and budgets.” commented Shiraz Austin, Co-Founder of Augnito and Managing Director at Scribetech (UK) Ltd.

“Scribetech was founded to provide acutely accurate, efficient, cost-effective, outsourced and in-house services and technology to support NHS clinical transcription. Augnito was developed as a result of 20 years of hands-on-experience delivering such services. Combining our digital dictation, transcription and speech recognition voice-AI offering as an augmented clinical administration solution is where we believe NHS organisations will start to see their digital transformation garnering the positive results they critically need across all care departments” concluded Austin.

END

Notes to editors
For further information, interview opportunities or accompanying graphics please contact: [email protected]

About Scribetech Textflow and Augnito
Visit https://www.scribetech.co.uk/ for more details.

[London, 7 December 2022] – Supporting a widespread remit to simplify and improve patient journeys, next-gen speech recognition is empowering pathology departments to work more efficiently.

At a key stage in the diagnostic process, pathology his a vital role to play in transforming healthcare and the experience of patients. However, cloud-based speech recognition provider Augnito identifies chronic underfunding and outdated technology as major barriers to new ways of working.

“NHS waiting lists are at record highs and, unless workflows change, they’re set to stay that way. Pathology has long been identified as key to diagnostic support outcomes and a priority for digitisation — but it’s not as simple as bringing in new technology. The relationship between old and new, manual and digital, pathologist and technology need to be carefully considered.” stated Shiraz Austin, Co-Founder of Augnito.

Today, pathology is a department that often goes unseen in the depths of the hospital campus. Most pathologists use very familiar ways of working on both macroscopic and microscopic analyses, often including a large amount of repetitive, manual transcription and reporting.

Many pathologists complete these complex workflows in outdated, legacy software. However, speech recognition and automation aren’t simply a way to replace this technology. Augnito makes even older software fully speech enabled.

Austin continued: “Pathology as a department is fairly resistant to change, which is why Augnito is so compelling for this use case. With our comprehensive API and SDK (Augnito Voice Services), we can integrate best-in-class, hands-free, accurate speech recognition into an existing EPR, EMR or LIMS. It’s a way for pathology to evolve how it works, without a complex or costly period of transition.”

Augnito is a cloud-hosted, AI-powered speech recognition solution, built in partnership with medical professionals. Integrated with existing systems or used via a standalone application, web browser, or smartphone/tablet, pathologists are empowered to report from anywhere — while continuing to meet the strict requirements of structured pathology reports.

Beyond simplifying workflows and increasing reporting speed, Augnito also facilitates closer collaboration and information sharing with other departments. As a cloud-hosted platform, data can be made securely available to colleagues for the next stage of the patient journey. In this sense, Augnito brings diagnostic systems and departments together to improve efficiency, research, innovation and — most importantly — patient care.

Austin concluded: “Accuracy is core to Augnito, but agility is equally important. Through our close connections with medical professionals in pathology, radiology and beyond, we’ve been able to develop a solution that looks at the needs of healthcare holistically. We’re confident that even small changes to how people work and an increased use of speech to save time could dramatically transform patient journeys.”

END

Notes to editors
Read the full blog post here www.scribetech.co.uk/2022/11/28/the-symbiosis-of-technology-in-diagnostic-reporting-how-sr-can-enhance-pathology

For further information, interview opportunities or accompanying graphics please contact: [email protected]

About Augnito
Augnito is a secure, cloud-based, AI-driven clinical speech recognition product suite. It offers fast, easy ways to capture live clinical data on any device with 99% accuracy, support for multiple medical specialities, and no need for voice profile training. Augnito brings seamless speech recognition to daily workflows and third-party clinical systems, turning medical information into clinical documentation and making healthcare intelligence securely accessible everywhere. Augnito was developed by its parent company, Scribetech, a clinical voice solutions innovator, fusing 20 years of transcription and digital dictation services to the NHS, speech-to-text, and clinical coding solutions for the healthcare sector, and its own speech recognition engine with advanced voice AI technology.

www.scribetech.co.uk/augnito-speechrecognition

 

[London, 29 November 2022] – Integrated into CIMAR’s cloud PACS solution in less than six months, Augnito helps clinical users create reports as much as 40-60% faster while working from anywhere.

Creating, accessing and sharing accurate medical information is the core of every radiologist’s workflow. As a result, the NHS, medical groups, imaging centres, and researchers are investing in sophisticated cloud technology to drive digital transformation, streamline image management, and improve clinician workflows.

CIMAR UK is a cloud-native Picture Archiving and Communication System (PACS), dedicated to making medical imaging and results securely accessible anywhere. Amid the COVID-19 pandemic, the CIMAR team saw a significant increase in demand for remote reporting, driven by lockdown requirements and an increase in remote working and working from home (WFM).

This accelerated the no longer desirable, but now essential, need for digital transformation and, ultimately, created an opportunity for CIMAR to maximise efficiency and flexibility for radiologists through speech-enabled diagnostic image reporting. Now, with the addition of Augnito’s AI-powered speech recognition, CIMAR can do even more to help radiologists work faster without compromising accuracy.

Dennis Wait, Chief Commercial Officer at CIMAR UK stated “There is little point having the flexibility of the cloud accessible remotely, without all the functionality that clinicians are used to having in the hospital. In our search for a cloud-based speech recognition solution provider to partner and integrate with, the ability to easily ‘talk’ to our cloud-based technologies was a critical element. We liked Augnito because it is cloud-native, as we are, it already used open API technology, and we appreciated its people-centred design approach. This aligns with our philosophy of finding a solution to a problem or challenge.”

“In terms of price, we found Augnito highly competitive and way beyond anything we had encountered in our SR solution search. We really wanted to pass that value on to our customers.” Continued Wait.

The Augnito integration with CIMAR’s cloud native PACS was completed in less than six months, with the first client using Augnito as part of the CIMAR solution soon after.

“Augnito’s team responsiveness, the solution’s API integration compatibility with our systems, coupled with its ease of use, simplicity, and ability to ‘unpack and go’ drove much of our decision-making process.” Added Wait.

Augnito is a cloud-hosted, AI-driven solution that can be accessed wherever needed. It also offers a comprehensive SDK and flexible API. This enables healthcare technology providers like CIMAR to bring highly accurate medical speech recognition, into existing clinical workflows and/or system platforms.

CIMAR also identified Augnito’s centrally updated language models as key to its success. These hosted models are designed to cover the vocabulary and terminology of multiple medical specialities, from radiology to cardiology. Users can switch between these models as necessary, ensuring complete coverage for every department and every kind of report.

“The agility and beautiful simplicity of having cloud-based SR available via any device and with a ‘portable’ profile allows a user the possibility to be anywhere in the world and still have access to a full suite of functionality. We’re still in the process of discovering how extensive Augnito can be, but it’s already an integral part of our solution offering to customers.” Concluded Wait.

For Augnito, this partnership represents a continued commitment to enabling radiologists to work more flexibly, 40-60% faster and highly accurately while coping with surmounting workloads and the backlog of existing reporting.

“CIMAR is a best-of-breed cloud PACS and Imaging Technology Innovation of the Year, 2022 Radiology Award Winner. We’re delighted that Augnito can play a role in helping CIMAR enable radiology departments to transform. Time-saving is an important advantage of using speech recognition (SR), but SR integrations also mean we can further expand that time-saving, by simplifying the working lives of clinicians, giving them a single system, available anywhere, that helps them accurately complete reports quickly and keep the patient journey moving.” Stated Shiraz Austin, Co-Founder of Augnito.

# # #  

Note to editors 

About Augnito
Augnito is a secure, cloud-based, AI-driven clinical speech recognition product suite. It offers fast, easy ways to capture live clinical data on any device with 99% accuracy, support for multiple medical specialities, and no need for voice profile training. Augnito brings seamless speech recognition to daily workflows and third-party clinical systems, turning medical information into clinical documentation and making healthcare intelligence securely accessible everywhere. Augnito was developed by its parent company, Scribetech, a clinical voice solutions innovator, fusing 20 years of transcription and digital dictation services to the NHS, speech-to-text, and clinical coding solutions for the healthcare sector, and its own speech recognition engine with advanced voice AI technology. Visit www.scribetech.co.uk/augnito-speechrecognition for more details.

About CIMAR
At Cimar we understand the challenges faced when it comes to managing today’s medical image data, demand for its access, and cross enterprise integration needs. Cimar’s services are true-cloud (Cloud-native) and arm you with award winning functionality designed to make it faster and simpler to store and share medical images securely, anywhere. We understand the limitless possibilities of the cloud and will help you reimagine your medical image management strategy to ensure its fit for your organisation and its future, safely and securely.